Results 41 to 50 of about 51,322 (300)
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an acquired autoimmune blistering dermatosis that is commonly associated with high morbidity and mortality. New-onset bullous pemphigoid following vaccinations has rarely been reported in the literature.
Vincent Wan +3 more
doaj +1 more source
The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid
Journal of the European Academy of Dermatology and Venereology, 2021 The influence of cutaneous cellular infiltration on the phenotype of bullous pemphigoid (BP) remains to be established.
S. Ständer +8 more
semanticscholar +1 more source
Annular bullous pemphigoid: A case report and review of literature
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an autoimmune blistering disease that primarily affects the geriatric population. It often presents as urticarial erythematous plaques, which evolve into subepidermal blisters accompanied by pruritus.
Steffie Arès +4 more
doaj +1 more source
Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.
JAMA dermatology, 2020 Importance The association between the use of medications and the development of bullous pemphigoid (BP) is unclear. Objective To assess the associations between previous exposure to certain medications and BP. Data Sources For this systematic review
Sian-De Liu, Wei-Ti Chen, C. Chi
semanticscholar +1 more source
New-Onset Bullous Pemphigoid in a COVID-19 Patient
Case Reports in Dermatological Medicine, 2021 This manuscript presents a report of bullous pemphigoid rash associated with COVID-19 for the first time. The objective of this manuscript is to present a unique dermatological case in the setting of a COVID-19-positive infection to further recognize the
N. Olson, David Eckhardt, Angela Delano
semanticscholar +1 more source
IgE autoantibodies and their association with the disease activity and phenotype in Bullous Pemphigoid: a systematic review [PDF]
, 2017 Bullous Pemphigoid (BP) is the most common autoimmune skin disease of blistering character. The underlying pathophysiological mechanism involves an immune attack, usually by IgG class autoantibodies, on the autoantigen BP 180/BPAg2, which is a type XVII ...
Fairclough, Lucy C. +3 more
core +2 more sources
Pemphigoid diseases in infancy and childhood. A review of the literature
Przegląd Dermatologiczny, 2023 Bullous pemphigoid is an autoimmune blistering disease that very rarely affects children. Clinical differences in locations of skin lesions led to the distinction of infantile versus childhood pemphigoid. Mucous membranes can be affected.
Magdalena Jałowska +2 more
doaj +1 more source
Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
Dermatology Practical & Conceptual, 2020 Autoimmune bullous disorders are a heterogeneous spectrum of skin disorders characterized by the production of autoantibodies against adhesion molecules of the skin. The 2 major groups of diseases are “pemphigus diseases” and “autoimmune bullous diseases
V. Di Lernia +3 more
semanticscholar +1 more source
Indian Journal of Dermatology, Venereology, and Leprology, 2011 Bullous pemphigoid (BP) is a relatively common autoimmune vesicobullous disease encountered in India. It is a subepidermal bullous disorder most commonly seen in the elderly and manifests as tense blisters on urticarial base, predominantly over flexures, and is associated with pruritus.
Sujay, Khandpur, Parul, Verma
openaire +2 more sources
Journal of the European Academy of Dermatology and Venereology, 2021 Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for cell‐matrix ...
N. Beek +15 more
semanticscholar +1 more source